A carregar...
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
Although all current antipsychotics act by interfering with the action of dopamine at dopamine D2 receptors, two recent reports showed that 800 to 1000 mg of cannabidiol per day alleviated the signs and symptoms of schizophrenia, although cannabidiol is not known to act on dopamine receptors. Becaus...
Na minha lista:
| Publicado no: | Transl Psychiatry |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315552/ https://ncbi.nlm.nih.gov/pubmed/27754480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2016.195 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|